Home
Granules India Ltd 52 Week Low

Granules India Ltd
NSE: GRANULES
YEARLOW
Key Highlights
- The 52 Week Low of Granules India Ltd is ₹ 389.15 as of 22 Apr 25 .
Company Fundamentals for Granules India Ltd
Market Price of Granules India Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
22 Apr 2025 | 480.5 |
21 Apr 2025 | 480.45 |
17 Apr 2025 | 467.4 |
16 Apr 2025 | 462.6 |
15 Apr 2025 | 464.35 |
11 Apr 2025 | 452.1 |
09 Apr 2025 | 431.2 |
08 Apr 2025 | 444.65 |
07 Apr 2025 | 436.8 |
04 Apr 2025 | 457.2 |
Asset Value vs Market Value of Granules India Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Granules India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Granules India Ltd
Historical Net Profit of Granules India Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Granules India Ltd
Granules India Ltd News Hub
Granules India Ltd soars 1.63%, up for third straight session
Granules India Ltd rose for a third straight session today. The stock is quoting at Rs 686.45, up 1.
Read more
21 Aug 24
Granules Pharmaceuticals receives USFDA approval for Glycopyrrolate Oral Solution
Granules India announced today that the U.S. Food and Drug Administration (FDA) has approved its Abb
Read more
20 Aug 24
Granules India rises on USFDA nod for oral drug Glycopyrrolate
The ANDA has been filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary o
Read more
20 Aug 24
Granules India receives US FDA nod for depression treatment drug Trazodone
It is bioequivalent and therapeutically equivalent to the reference listed drug Desyrel Tablets of P
Read more
09 Aug 24